| USD millions | FY2021 | FY2022 | FY2024 | FY2023 | FY2024 | FY2025 | TTM | Trend | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | โ | 0.0 | 0.0 | 0.0 | โ | โ | |
| Cost of revenue | 0.0 | 0.0 | โ | 0.0 | 0.0 | 0.0 | โ | โ | |
| Gross profit | 0.0 | 0.0 | โ | 0.0 | 0.0 | 0.0 | โ | โ | |
| Research & development | 1.4 | 10.5 | 10.5 | 4.1 | 6.4 | 10.2 | 7.0 | โ31.9% | |
| Selling, general & administrative | 0.3 | 1.4 | โ | 3.2 | 2.4 | 2.8 | โ | โ | |
| Selling & marketing | 0.0 | 0.0 | โ | 0.0 | 0.0 | 0.0 | โ | โ | |
| Operating expenses | 1.7 | 1.6 | 11.1 | 7.3 | 8.8 | 13.1 | 9.8 | โ25.0% | |
| Operating income | (1.7) | (1.6) | (11.1) | (7.3) | (8.8) | (13.1) | (9.8) | +25.0% | |
| Interest expense | 0.0 | 0.0 | โ | 0.0 | 0.0 | 0.0 | โ | โ | |
| Interest income | 0.0 | 0.7 | โ | 0.0 | 0.0 | 0.0 | โ | โ | |
| Other income / expense | 1.4 | 0.7 | โ | 0.0 | 0.0 | 0.0 | โ | โ | |
| Pre-tax income | (1.7) | (0.9) | (11.1) | (7.3) | (8.8) | (13.1) | (10.0) | +23.3% | |
| Income tax | (0.2) | 0.1 | โ | 0.0 | 0.0 | 0.0 | โ | โ | |
| Net income | (1.7) | (1.0) | (11.1) | (7.3) | (8.8) | (13.1) | (10.0) | +23.4% | |
| Discontinued operations | 0.0 | 0.0 | โ | 0.0 | 0.0 | 0.0 | โ | โ | |
| Other net income adjustments | (1.4) | 0.0 | โ | 0.0 | 0.0 | 0.0 | โ | โ | |
| EPS, basic (per share) | (0.29) | (0.17) | (36.35) | (0.21) | (0.25) | (0.35) | โ | โ | |
| EPS, diluted (per share) | (0.29) | (0.17) | (36.35) | (0.21) | (0.25) | (0.35) | โ | โ | |
| EBITDA | (0.0) | (0.7) | โ | (7.3) | (8.8) | (13.1) | โ | โ | |
| Depreciation & amortization | 0.2 | 0.2 | โ | 0.0 | 0.0 | 0.0 | โ | โ | |
| Weighted average shares (shares) | 5,849,700 | 5,762,911 | 305,748 | 35,201,232 | 36,680,870 | 36,820,810 | โ | โ | |
| Weighted average diluted shares (shares) | 5,849,700 | 5,762,911 | 305,748 | 35,201,232 | 36,680,870 | 36,820,810 | โ | โ |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.